HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Teresa Di Martino Selected Research

Biomarkers (Surrogate Marker)

3/2024Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.
7/2022Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease.
3/2022miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.
1/2022Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
3/2021miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
11/2020Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis.
11/2020Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.
3/2020DMETTM Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine.
12/2018Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
1/2017Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Teresa Di Martino Research Topics

Disease

39Neoplasms (Cancer)
03/2024 - 01/2007
24Multiple Myeloma
01/2023 - 10/2012
6Breast Neoplasms (Breast Cancer)
03/2024 - 04/2009
4Genomic Instability
01/2021 - 01/2019
3Hematologic Neoplasms (Hematological Malignancy)
03/2018 - 01/2016
2Inflammation (Inflammations)
03/2024 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2023 - 09/2014
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2022 - 01/2021
2Rare Diseases (Rare Disease)
01/2021 - 03/2020
2Fabry Disease (Fabry's Disease)
12/2017 - 12/2016
1Tics (Tic)
03/2024
1Cardiotoxicity
03/2024
1Type 2 Diabetes Mellitus (MODY)
08/2023
1Diabetes Mellitus
08/2023
1Sarcoma (Soft Tissue Sarcoma)
03/2023
1Adenocarcinoma of Lung
01/2023
1Diabetes Complications
07/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
07/2022
1Albuminuria
07/2022
1Prostatic Neoplasms (Prostate Cancer)
06/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Paraproteinemias (Monoclonal Gammopathy)
01/2021
1Idiopathic Pulmonary Fibrosis
11/2020
1Melanoma (Melanoma, Malignant)
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Triple Negative Breast Neoplasms
02/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Disease Progression
12/2017
1Exanthema (Rash)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Hypoxia (Hypoxemia)
05/2014
1Bone Diseases (Bone Disease)
07/2013

Drug/Important Bio-Agent (IBA)

22MicroRNAs (MicroRNA)IBA
03/2022 - 10/2012
13Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2013
6LNA-i-miR-221IBA
01/2023 - 01/2014
5locked nucleic acidIBA
01/2023 - 01/2014
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2012
4EnzymesIBA
01/2022 - 01/2016
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2014
3Proteins (Proteins, Gene)FDA Link
12/2017 - 02/2013
3mouse MIRN29 microRNAIBA
12/2013 - 10/2012
2CytokinesIBA
03/2024 - 06/2022
2Long Noncoding RNAIBA
08/2023 - 01/2023
2DNA Ligase ATPIBA
10/2022 - 01/2019
2AntigensIBA
06/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
03/2021 - 11/2020
2Monoclonal AntibodiesIBA
03/2021 - 01/2021
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2019 - 11/2011
2GalactosidasesIBA
12/2017 - 12/2016
2Untranslated RNA (Noncoding RNA)IBA
09/2016 - 06/2013
2Transcription Factors (Transcription Factor)IBA
08/2015 - 05/2014
2LipidsIBA
01/2014 - 01/2014
2Nucleic AcidsIBA
01/2014 - 01/2014
2PlatinumIBA
10/2009 - 04/2009
1Trastuzumab (Herceptin)FDA Link
03/2024
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
03/2024
1Cytochrome P-450 CYP3AIBA
03/2024
1Blood Glucose (Blood Sugar)IBA
08/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2023
1FlavonoidsIBA
10/2022
1rhamnetinIBA
10/2022
1Glycoproteins (Glycoprotein)IBA
06/2022
1Lenalidomide (CC 5013)FDA Link
08/2021
1Chimeric Antigen ReceptorsIBA
03/2021
1AntibodiesIBA
03/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1OligonucleotidesIBA
12/2019
1B-Cell Maturation AntigenIBA
12/2019
1MethylcholanthreneIBA
08/2019
1IntegrinsIBA
02/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2019
1Estrogen ReceptorsIBA
02/2019
1GTP-Binding Proteins (G-Protein)IBA
02/2019
1Estrogens (Estrogen)FDA Link
02/2019
1Growth Factor ReceptorsIBA
02/2019
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2019
1TrabectedinIBA
01/2019
1taxaneIBA
01/2019
1Drug Receptors (Drug Receptor)IBA
12/2018
1CalreticulinIBA
12/2017
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
12/2017
1multidrug resistance-associated protein 1IBA
03/2016
1Staphylococcal Protein A (Protein A)IBA
03/2016
1Melphalan (Alkeran)FDA LinkGeneric
03/2016
1Large Neutral Amino Acid-Transporter 1IBA
03/2016
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2016
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
01/2016
1Cholecalciferol (Vitamin D3)FDA Link
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1ChitosanIBA
12/2015
1PhytochemicalsIBA
09/2014
1Transferrin (beta 2 Transferrin)IBA
01/2014
1MethyltransferasesIBA
12/2013

Therapy/Procedure

11Therapeutics
01/2023 - 01/2007
6Immunotherapy
06/2022 - 12/2018
2Precision Medicine
01/2022 - 01/2022
1Prostatectomy (Retropubic Prostatectomy)
06/2022
1Enzyme Replacement Therapy
12/2017
1Drug Therapy (Chemotherapy)
09/2014